Beleave’s (CNSX:BE) Health Canada approval to cultivate cannabis was spotlighted on Financial Post. According to the article, “Five months ago, publicly traded medical marijuana companies already had a combined market value of $3 billion, but the legalization of recreational marijuana could expand their revenue significantly. Last year, CIBC World Markets predicted that legalized recreational marijuana could become a $10-billion-a-year industry; other analysts put that number even higher.”
Click here to read the full article.
Click here to connect with Beleave (CNSX:BE) to receive an Investor Presentation.
Centurion Executes Definitive Agreement with Canadian Cannabis Beverage Company, Amends Uruguay Cannabis CBD Oil Extraction Agreement
February 25 | 2021
Centurion to acquire a Disruptive Water-Soluble Cannabinoid Technology Platform Delivering Rapid Onset, Increased Bioavailability, Premium Taste Profiles and Highly Competitive Cost Structure
Centurion Minerals Ltd. (TSXV: CTN) (FSE: XJCB) (“Centurion” or the “Company”) is pleased to announce that it has entered into an Amalgamation Agreement dated February 17, 2021 (the “Agreement”), with HAI Beverages Inc. (“HAI”), whereby Centurion will acquire 100% of the outstanding shares and assets of a wholly-owned subsidiary of HAI (“NewHAI) in exchange for common shares of Centurion (the “Acquisition” or “Transaction”). NewHAI holds all material assets of HAI and the Acquisition will constitute a reverse take-over (“RTO”) of the Company.
<p><b>About HAI</b></p>
<p>The HAI team has extensive experience in the beverage and consumer packaged goods industries, founding HAI to capitalize on the disruption of the alcohol beverage market by cannabis infused products. The HAI team’s deep understanding of the global beverage market and its experience in developing successful beverage brands, resulted in a proprietary technology platform that delivers:</p>
<ul class="ee-ul"><li>Rapid onset and high bioavailability, providing an experience similar to the sessionability of alcohol consumption;</li>
<li>A cost structure competitive with non-infused, mass market beverages; and</li>
<li>Multi-format product capabilities.</li>
</ul><p>HAI has developed an extensive portfolio of technology and assets related to water-soluble cannabinoids (THC, CBD, and other cannabinoids), including:</p>
<ol class="ee-ol"><li>A range of ready-to-drink beverage products targeting specific consumer groups. </li>
<li>Seltzers, sodas, and a variety of carbonated cocktail formulations.</li>
<li>Single-serve powdered drink offerings utilizing HAI’s dry water-soluble technology. </li>
<li>Teas, coffee, and mate (also known as cimarron), including K-Cup single serve formats, using a dry water-soluble formulation.</li>
<li>A suite of advanced topical products that utilizes HAI’s concentrates to enable rapid transdermal delivery of the active cannabinoid ingredients.</li>
</ol><p>The HAI research team has successfully developed multiple infused beverage products containing highly bioavailable cannabinoids that deliver an equivalent experience to alcohol consumption and importantly, result in a rapid onset (within 3 to 5 minutes, compared to other available products having an onset of 15 to 45 minutes). The intellectual property Hai has developed around bioavailability and rapid onset led to HAI’s first patent application.</p>
<p><b>Go-to-Market Strategy</b></p>
<p>HAI is implementing a two-prong, go-to-market strategy, focused on: </p>
<p>1) Procuring agreements with current licensed producers to manufacture branded and white-labelled water-soluble cannabis, in ready-to-drink and dry formulations; and </p>
<p>2) Royalty based licensing of intellectual property (the “<b>IP</b>“) and processes to 3<sup>rd</sup> parties.</p>
<p>Centurion and HAI intend to pursue a cannabis beverage consumer packaged goods licensing and joint venture strategy anchored on the CannaEden operations in Punta del Este, Uruguay. Through the CannaEden operation, and within legal jurisdiction parameters, the Company intends to initially pursue sales in Brazil, Argentina and Paraguay. Centurion and CannaEden have advanced discussions with multiple South American pharmaceutical and consumer packaged goods companies in a co-ordinated effort to quantify potential domestic and international markets as well as determine feasible products and distribution networks.</p>
<p>The Company will also continue to develop and advance markets of initial focus for HAI, including Mexico, Canada, and the U.S.-based Latino markets (a significant, but largely underserved, demographic group). Activity in the U.S. would be limited to CBD-infused beverage manufacturing or licensing of IP within the legal guidelines established by the target jurisdictions and policies of the TSX Venture Exchange (the “<b>TSX-V</b>“).</p>
<p>David Tafel, CEO of the Company commented: <i>“We are incredibly pleased to have finalized the Agreement with HAI. We set out to create a company that would be strongly differentiated and able to deliver outsized value to its shareholders. We believe that HAI through its unique technology platform, exceptional management team, and focused go-to-market strategy, is the right transaction to build on this vision. With the global cannabis industry rapidly transforming, we feel that HAI is uniquely positioned to capitalize on developing opportunities.” </i></p>
<p>Bruce Clark, HAI’s CEO, additionally commented: <i>“We strongly believe that cannabis infused consumer packaged goods are the future of the global cannabis industry. We have spent several years developing proprietary IP and processes associated with water-soluble cannabinoids. The merger with Centurion and CannaEden represents the next major step in our development as we jointly execute on our strategy, leveraging a brilliant platform for growth in South America, Mexico and North America.”</i> </p>
<p><b>HAI Transaction Summary</b></p>
<p>Upon closing, Centurion will issue 30 million shares in exchange for 100% of the issued and outstanding shares and assets of NewHAI. The Transaction will be an arm’s-length transaction and will not be a related party transaction, under applicable securities rules. NewHAI shareholders will have the ability to earn up to an additional 38,428,500 million shares upon hitting corporate milestones related to achieving certain revenue objectives. No deposit or advance has been made or is anticipated to be made by Centurion to HAI or NewHAI in connection with the Transaction and HAI will continue to finance its own activities until closing of the transaction. </p>
<p>The Transaction is subject to a number of terms and conditions, including, but not limited to, receipt of all necessary Board, shareholder and any regulatory approvals; completion of the financings described below; and approval of the TSX-V. </p>
<p>Centurion will provide a summary of any available significant financial information for HAI and NewHAI in the near future and will also confirm in a subsequent news release whether it will retain a Sponsor pursuant to the Transaction and concurrent financing or whether it will rely upon any available exemptions or waivers from the TSX-V. There can be no assurance that the Transaction will be completed as proposed or at all.</p>
<p>Trading in the shares of Centurion is expected to remain halted pending receipt of conditional approval from the TSX-V and/or closing of the Transaction.</p>
<p><b>Financing</b></p>
<p>Pursuant to the Agreement, it is a condition of closing that HAI and the Company (the “<b>Parties</b>“) will have completed a concurrent financing of a minimum $2,500,000 (the “<b>Financing</b>“). The Parties intend to undertake the Financing by way of private placement at $0.50 per Unit. Each Unit will consist of one common share and one share purchase warrant. The Parties anticipate that each Warrant shall have a term of 24 months commencing on the Closing Date and shall entitle the holder to purchase one common share at a price of $0.65. </p>
<p><b>Centurion Consolidation</b></p>
<p>Concurrent with the Transaction closing, the Company intends to undertake a share consolidation whereby 2 common shares shall be exchanged for 1 post-consolidation common share of the Company. The number of stock options, warrants and related exercise prices will also be adjusted in accordance with the consolidation ratio. For reference, the Company currently has 33,639,473 common shares issued and outstanding, as well as 416,667 stock options exercisable at an average price of $.60 per share and 20,112,575 warrants to acquire Centurion shares exercisable at an average price of $0.15 per share. </p>
<p><b>CannaEden Amending Agreement</b></p>
<p>Pursuant to the Company’s news release February 7, 2020, the Company has amended its original share purchase agreement (the “<b>CannaEden Amending Agreement</b>“) with the Uruguayan group of companies doing business as CannaEden (“<b>CannaEden</b>“) to align with the Company’s planned share consolidation discussed above and the Financing. The CannaEden Amending Agreement amends certain provisions such that at closing, Centurion will issue 5 million shares (previously 10 million shares) in exchange for 100% of the issued and outstanding shares and assets of CannaEden. CannaEden will have the ability to earn up to an additional 3 million shares (previously 6 million shares) upon hitting the same revenue milestones as discussed above for NewHAI. The Company has also agreed to amend the Bridge Financing provision whereby CannaEden will have the option to receive either cash reimbursement, or common shares of the Company valued at $0.50, for expenditures incurred between execution date of the original share purchase agreement and closing of the Transaction. </p>
<p><b>Board of Directors and Management of the Resulting Issuer</b></p>
<p>Upon completion of the Transaction, it is intended that David Tafel and Jeremy Wright will continue to serve on the board of directors of the Company, and Bruce Clark, Chris Hoffmeister, and Edward Lupton will be appointed representing NewHAI, and as previously announced, Mauricio Zlatkin will be appointed representing CannaEden. Kenneth Cawkell and Joseph Del Campo will resign as Directors of the Company upon completion of the Transaction. Operationally, Bruce Clark will assume the role of Chief Executive Officer, David Tafel will assume the role of Executive Co-Chairman and Jeremy Wright will continue as the Chief Financial Officer. Mauricio Zlatkin will assume the role of General Manager, Uruguay. </p>
<p>David Tafel, CEO of the Company commented: <i>“We are incredibly grateful for the tireless efforts of Ken and Joe as Directors of Centurion. Their contributions, advice and friendship have been very valuable to us, and we truly thank both of them. At the same time, we are eager to move forward with this transaction and work with the incoming HAI and CannaEden team members.”</i> </p>
<p>A brief biography of the Directors and Officers is provided here:</p>
<p><u><b>Mr. David Tafel – Director, Executive Co-Chairman </b></u></p>
<p>Mr. Tafel holds a B.A. in Economics from the University of Western Ontario and has over 30 years of corporate structuring, strategic planning, financing, administration and management experience. He has been an officer, director and founder of a number of publicly listed companies and has been instrumental in raising well over $100 million for resource, life sciences and technology companies.</p>
<p><u><b>Mr. Bruce Clark – Director, President & CEO</b></u></p>
<p>Mr. Clark is the CEO and co-founder of HAI Beverages, an innovator in alternative beverages. He has deep expertise in beverage manufacturing & operations. As former Vice President at the Pacific West Brewing Company, he engineered two separate turnarounds over a 20-year period. He has been responsible for the successful launch of multiple brands, driving revenues and delivering sustainable solid profitability. Mr. Clark is also the Principal in the Broadwing Group, a project services and holding company that has worked on many commercial ventures over the past 20 years. With a focus on energy, he has been instrumental in the conception, finance, and development of a number of large projects. The Company has remained engaged in all projects participated in. </p>
<p><u><b>Mr. Jeremy Wright, CPA, CMA – Director, Chief Financial Officer</b></u></p>
<p>In addition to his current role as a Director and CFO for Centurion Minerals Ltd., Mr. Wright has broad experience working with senior management developing strategies and solutions to business issues mainly related to corporate finance, cost and risk management, and governance. Mr. Wright is a Chartered Professional Accountant (Certified Management Accountant), currently serves as a director for several public and private companies including Pontus Protein Ltd., RAYL Innovations Inc. Mr. Wright previously served as a director of TGS Esports Inc., Freeform Capital Partners Inc., Pacific Community Resources Society and the Canadian Freestyle Ski Association. In addition, Mr. Wright also serves as the CFO for several public and private companies, including Portofino Resources Inc., and Alpha Cognition, Inc. He was previously the CFO for GTEC Cannabis Co., an ultra-premium cannabis producer having three federally licensed production facilities across Canada. Mr. Wright also holds a Bachelor of Arts, with honours in Environmental Economics, from Brock University. </p>
<p><u><b>Mr. Mauricio Zlatkin – Director, General Manager (Uruguay)</b></u></p>
<p>Mr. Zlatkin is CannaEden’s Managing Partner. A lawyer by training with a degree from Rio de Janeiro State University (UERJ), he specialized in Finance and Derivatives Trading in Chicago and New York. He has been a member of the São Paulo Commodities and Futures Exchange from 1987 until it’s IPO in 2007, and with the Chicago Mercantile Exchange (CME) from 1995 to present, having acted as a Floor Trader, Broker, Fund Manager and Private Investor. His business ownership career commenced in 2004 after moving to Uruguay where he is currently Managing Partner in a number of companies with activities in the Real Estate, Aviation Services, Hospitality and Winemaking industries.</p>
<p><u><b>Mr. Chris Hoffmeister – Director, Co-Chairman</b></u></p>
<p>Mr. Hoffmeister is the CEO of Select Wines, one of Canada’s largest wine importers and distributors. Mr. Hoffmeister has 21 years of beverage alcohol marketing and sales experience. Mr. Hoffmeister joined Select Wines in 2011 and helped lead a management buyout in 2017. Prior to Select, Mr. Hoffmeister was at the Mark Anthony Group where he had a wide range of roles including Agency Brands Marketing Director and General Manager of the Wine Division. His marketing experience includes work on world class beverage brands such as Corona Beer, Concha y Toro, Marchese Antinori. Patron Tequila and Remy Martin Cognac. Prior to Mark Anthony, Mr. Hoffmeister was a Principal with Sierra Systems with focus on providing management consulting to companies in the Natural Resource sector. Mr. Hoffmeister is a graduate of Queen’s University and a member of the Young Presidents Organization. </p>
<p><u><b>Mr. Edward Lupton – Director</b></u></p>
<p>Mr. Lupton is the Executive Chairman of Select Wines, one of Canada’s largest wine importers and distributors. Mr. Lupton has three decades of experience as an entrepreneur operating, acquiring and divesting businesses both in Asia and North America including businesses sold to divisions of ADP, the UK Royal Mail and Axel Springer SE. He holds a BA with Honours from Nottingham University, England.</p>
<p><b>Name Change</b></p>
<p>Subject to receipt of any necessary shareholder, Board of Director and or regulatory approvals, and coincidental with closing of the Transaction, the Parties propose to change the name of the Company to <b>HAI Technologies Inc</b>.</p>
<p><b>ABOUT CENTURION </b></p>
<p>Centurion Minerals Ltd. is a Canadian-based company with a focus on South American asset development. The Company’s lead investment has been its interest in the Ana Sofia Agri-Gypsum Fertilizer Project. The Company has been actively pursuing business opportunities in the South American cannabis and related products industry.</p>
<p> <i><b>“David G. Tafel”<br/></b></i>President and CEO</p>
<p><b>For Further Information Contact:<br/></b>David Tafel<br/>604-484-2161</p>
<p><i>Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.</i></p>
<p>Completion of the transaction is subject to a number of conditions, including, but not limited to, Exchange acceptance and if applicable, shareholder approval. Where applicable, the transaction cannot close until the required shareholder approval is obtained. There can be no assurance that the transaction will be completed as proposed or at all. Investors are cautioned that, except as disclosed in the management information circular or filing statement to be prepared in connection with the transaction, any information release or received with respect to the transaction may not be accurate or complete and should not be relied upon.</p>
<p>This news release contains forward looking statements concerning future operations of Centurion Minerals Ltd. (the “Company”). All forward-looking statements concerning the Company’s future plans and operations, including management’s assessment of the Company’s project expectations or beliefs may be subject to certain assumptions, risks and uncertainties beyond the Company’s control. Investors are cautioned that any such statements are not guarantees of future performance and that actual performance and financial results may differ materially from any estimates or projections. Such statements include, among others: conclusions of future economic evaluations; changes in project parameters as plans continue to be refined; failure of equipment or processes to operate as anticipated; accidents and other industry risks; delays and other risks related to construction activities and operations; timing and receipt of regulatory approvals of operations; the ability of the Company and other relevant parties to satisfy regulatory requirements; the availability of financing for proposed transactions, programs and working capital requirements on reasonable terms; the ability of third-party service providers to deliver services on reasonable terms and in a timely manner; market conditions and general business, economic, competitive, political and social conditions. </p>
<p>NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.</p>
<p id="corporateNewsLogoContainer"><img alt="Corporate Logo" class="lazy" data-src="https://orders.newsfilecorp.com/files/4407/75471_68f5a96474124ab3_logo.jpg" data-srcset="" id="corporateNewsLogo" src="https://orders.newsfilecorp.com/files/4407/75471_68f5a96474124ab3_logo.jpg" srcset=""/></p>
<p id="corporateLinkBack">To view the source version of this press release, please visit <a href="https://www.newsfilecorp.com/redirect/0zGxsrw7A" rel="noopener noreferrer" target="_blank">https://www.newsfilecorp.com/release/75471</a></p>
<p><img alt="" class="lazy" data-src="https://www.newsfilecorp.com/newsinfo/75471/310" data-srcset="" src="https://www.newsfilecorp.com/newsinfo/75471/310" srcset=""/></p>
</div>
<p>News Provided by Newsfile via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
Cresco Labs Announces Upcoming Investor Conference Participation
February 25 | 2021
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today its participation in the following investor conferences:
- Needham 2nd Annual Virtual Cannabis Conference – March 3 rd , 2021 – Management will participate in virtual one-on-one meetings.
- 33rd Annual Roth Conference – March 15 th -17 th , 2021 – Charlie Bachtell, CEO and Co-Founder, will participate in a Fireside Chat and management will later participate in virtual one-on-one meetings on April 7 th .
- Stifel Multi-Sector Conference – April 21 st , 2021 – Management will participate in virtual one-on-one meetings.
About Cresco Labs
<p> Cresco Labs is one of the largest vertically integrated, multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted brands including Cresco, Remedi, High Supply, Cresco Reserve, Good News, Wonder Wellness, FloraCal Farms and Mindy’s Chef Led Artisanal Edibles created by James Beard Award-winning chef Mindy Segal. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at <a href="https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.crescolabs.com%2F&esheet=52385445&newsitemid=20210225005300&lan=en-US&anchor=CrescoLabs.com&index=1&md5=ed7e876082e8d9a12fc80a6cc33c6be6" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> CrescoLabs.com </a> . </p>
<p> <b> Forward Looking Statements </b> </p>
<p> This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the company’s Annual Information Form dated April 28, 2020, and other documents filed by the Company with Canadian securities regulatory authorities; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco’s shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise. </p>
<p> <img alt="" class="lazy" data-src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20210225005300r1&sid=quot2&distro=nx&lang=en" data-srcset="" src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20210225005300r1&sid=quot2&distro=nx&lang=en" srcset=""/><span></span> </p>
<p id="mmgallerylink"> <span id="mmgallerylink-phrase"> View source version on businesswire.com: </span> <span id="mmgallerylink-link"> <a href="https://www.businesswire.com/news/home/20210225005300/en/" rel="nofollow noopener noreferrer" target="_blank"> https://www.businesswire.com/news/home/20210225005300/en/ </a> </span> </p>
<p> <i> Media: </i> <br/> Jason Erkes, Cresco Labs <br/> Chief Communications Officer <br/><a href="mailto:press@crescolabs.com" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> press@crescolabs.com </a> </p>
<p> <i> Investors: </i> <br/> Jake Graves, Cresco Labs <br/> Manager, Investor Relations <br/><a href="mailto:investors@crescolabs.com" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> investors@crescolabs.com </a> </p>
<p> <i> For general Cresco Labs inquiries: </i> <br/> 312-929-0993 <br/><a href="mailto:info@crescolabs.com" rel="nofollow noopener noreferrer" shape="rect" target="_blank"> info@crescolabs.com </a> </p>
</div>
<p>News Provided by Business Wire via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
Green Thumb Industries Continues Community Investment Initiatives with Scholarships and Expanded Partnerships to Promote Diversity in the Cannabis Industry
February 25 | 2021
Green Thumb Industries, a leading cannabis consumer packaged goods company and owner of Rise™ Dispensaries, is expanding key partnerships and creating scholarships earmarked for those from communities most impacted by the war on drugs as part of its corporate social responsibility program. The scholarships will be granted to a total of four students for programs at the Cleveland School of Cannabis in Ohio and Olive-Harvey College in Illinois. Additionally, Green Thumb will continue its support of Cabrini Green Legal Aid and partner with the North Lawndale Employment Network in Chicago as part of ongoing collaborations that include financial support, volunteerism and awareness initiatives.
Building on the foundation of Green Thumb’s LEAP initiative, which provided pro-bono support for social equity license applicants in Illinois and which will soon offer business incubator resources to newly awarded social equity entrepreneurs, these impactful partnerships mark a critical next step in prioritizing diversity, equity, and inclusion in the cannabis industry.
<p> “Education is the foundation of opportunity and the Green Thumb team is honored to support scholarships that create pipelines of diversity into the cannabis industry, specifically by partnering with nonprofits that address issues facing communities disproportionally impacted by the war on drugs,” said Green Thumb Corporate Social Responsibility Director Michael Fields. “We believe it is our responsibility to continue to help reduce barriers to entry, increase diversity and promote opportunity throughout the industry.” </p>
<p> The programs with available scholarships include: </p>
<p> <strong> Cleveland School of Cannabis: </strong> The Cleveland School of cannabis will award a “Resilience Scholarship” to two students impacted by the war on drugs, as determined by an independent application review committee, funded by Green Thumb. The mission of the Cleveland School of Cannabis is to foster adult learning through high-quality, residential and online education that integrates personal development along with career-oriented skills and knowledge related to cannabis, science, and business, to prepare graduates for entry-level employment in the industry. Tuition covers all resources and fees needed to complete the 150-hour on-line cannabis certificate program. For more information visit <a href="https://www.globenewswire.com/Tracker?data=rGzPXJyY0NV5jEtfyhHgR8KWsKPHgu1NSZMlme_--OeLTXhVGCS1GGksICSiXXqFZWQHqYzbtz1iOacXtcomYtbaPNEPgGTKnVfriMZ7VPs=" rel="nofollow noopener noreferrer" target="_blank"> www.csceducation.com </a> . </p>
<p> “Without education any plans for equity will not be sustainable. We are grateful to Green Thumb for their support in helping us achieve our goals,” said Vice President of CSC Kevin Green. </p>
<p> <strong> Olive-Harvey College: </strong> The mission of the Cannabis Studies program at City Colleges of Chicago is to educate the future workforce, activists, thought leaders and entrepreneurs in the Illinois cannabis industry and empower individuals who have been disproportionately affected by the War on Drugs through restorative justice. The two scholarships will cover tuition and all resources and fees needed to complete the 11-credit certificate course. For more information visit <a href="https://www.globenewswire.com/Tracker?data=Tif5eLaMc4Dqvj-wI6Php4iJakOrkSJzjlH-F-gfcYIeCXbupNNLOldLH8qI9ordElpOAjtuH5qJp3MHPu9yvYowW0RjOnFUmED9spoEqaR4JkO_ydom6OhShBkgWsCjpB5KDgxucNrm7mRwgZ4wBQ==" rel="nofollow noopener noreferrer" target="_blank"> www.ccc.edu </a> . </p>
<p> “Olive-Harvey College is grateful for partners such as Green Thumb, who support our program with speaker series, engagement and tuition support,” said Executive Director of Strategic Initiatives at Olive-Harvey College Amanda Gettes. </p>
<p> Those interested in applying for scholarships should contact the schools directly. </p>
<p> Green Thumb is also partnering with the following nonprofit organizations undertaking necessary and important work in Chicago: </p>
<p> <strong> Cabrini Green Legal Aid: </strong> Established in 1973, CGLA’s mission is to seek justice and mercy for those living in poverty by providing legal services that strengthen individual lives, families, and communities. They aim to proactively fill the void of legal representation, wraparound services, and advocacy for individuals affected by the criminal justice system. Green Thumb volunteers will continue to work with CGLA’s team to provide a variety of legal services associated with criminal records relief services. For more information visit <a href="https://www.globenewswire.com/Tracker?data=ZB9s-2NlqCaHnbDLcnoSie1dc7LFQz6qPN1vluhqouK_-11agLXK58qUrjXW8lBTbF9OLTDtRJrQiJovi8dhqcnpRCdjNpkuFLVPRo-hCNHQTujX1hHXFUba6yMr6NkNJTCWnpcZdwcmREaCVxr9p4pSTdTcnFnooI_tth29UqnsgRebdHPEsIP8nmUY_CKIe6cSKI63v6pfacCLrzaeAOQOBdmOXYwjrkO-t_tQB9lV3D9zNiUwJlqBm6MbpB7Ku98CSf47k1IV92nhKGDXakEj8ju97GgXFnYJ5dTtUsBZSI_A427u7x6epQkDLhUjWUq7Hkj7Om_5YTYoGq7pN_XLGNK6m2tuj_RgRageoOmtO81YdFNPfmkgaEh0McP713i11Sc0wJqDh8pAdiTsQS_vFs0-fwlaCXYngbRUXAQit7j41FHFAPf1K10BXSD6UtCehGNpJCg3yeDPwrdri3Ly563t_4SQTuiXKJ7TkeMuxMKwAI_ogFeVE2scSM7MJ2D-pscolfuKaAZ53jCpRyAyTY_NVkBniLwJdMyRZy4XZpEKIfIX4mqH5TbTgxk4" rel="nofollow noopener noreferrer" target="_blank"> www.cgla.net </a> . </p>
<p> “CGLA is extremely excited to partner with Green Thumb as we collaborate to fulfill the social equity components of the Illinois’ Cannabis Act. It is extremely important for us to remove the barriers that prevent access to ownership and employment in the industry for individuals and communities negatively impacted by the criminal justice system. We are grateful for what this partnership will bring and look forward to welcoming Green Thumb volunteers into the CGLA family,” said Cabrini Green Legal Aid Executive Director Esther Franco-Payne. </p>
<p> <strong> North Lawndale Employment Network: </strong> NLEN serves under and unemployed residents of Chicago’s North Lawndale neighborhood and surrounding communities. Clients include citizens returning from incarceration and others who face the day-to-day hardships of living without enough income to support themselves and their families. In addition to contributing financial resources, the Green Thumb team will work closely with NLEN to help deliver necessary and important services to their clientele. For more information visit <a href="https://www.globenewswire.com/Tracker?data=9V_7S--TqM8M5rVsXcpDd0Ux-pvUBxUuIt2FBeWlS3qdAmQvTaGFHTTSl_SDSn_1sTdvp8FJKYgJbQvr8L8xnw==" rel="nofollow noopener noreferrer" target="_blank"> www.nlen.org </a> . </p>
<p> “We are thrilled to partner with Green Thumb to further improve the quality of life and bridge the racial wealth gap through advancing digital inclusion on Chicago’s West Side. I know that much good will grow from our partnership,” said Executive Director of the North Lawndale Employment Network Brenda Palms Barber. </p>
<p> <strong> About Green Thumb Industries </strong> : </p>
<p> Green Thumb Industries Inc. (“Green Thumb”), a national cannabis consumer packaged goods company and retailer, promotes well-being through the power of cannabis while giving back to the communities in which it serves. Green Thumb manufactures and distributes a portfolio of branded cannabis products including Beboe, Dogwalkers, Dr. Solomon’s, incredibles, Rythm and The Feel Collection. The company also owns and operates rapidly growing national retail cannabis stores called Rise™. Headquartered in Chicago, Illinois, Green Thumb has 13 manufacturing facilities, licenses for 97 retail locations and operations across 12 U.S. markets. Established in 2014, Green Thumb employs over 2,300 people and serves thousands of patients and customers each year. The company was named a Best Workplace 2018 by Crain’s Chicago Business and MG Retailer magazine in 2018 and 2019. More information is available at <a href="https://www.globenewswire.com/Tracker?data=TVuZIXqkvhgZFvJP98Fso5885CXCrlyuEUeOrj4cbGgt5r-eCodBb8akgnfB1nUVVAzmA9x_dGNnYlAyXGtJxQ==" rel="nofollow noopener noreferrer" target="_blank"> GTIgrows.com </a> . </p>
<div>
<table><tbody><tr><td> <strong> Investor Contact: </strong> </td>
<td> </td>
<td> </td>
<td> <strong> Media Contact: </strong> </td>
</tr><tr><td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr><tr><td> Jennifer Dooley </td>
<td> </td>
<td> </td>
<td> Linda Marsicano </td>
</tr><tr><td> Chief Strategy Officer </td>
<td> </td>
<td> </td>
<td> VP, Corporate Communications </td>
</tr><tr><td> <a href="mailto:InvestorRelations@gtigrows.com" rel="nofollow noopener noreferrer" target="_blank"> InvestorRelations@gtigrows.com </a> </td>
<td> </td>
<td> </td>
<td> <a href="mailto:lmarsicano@gtigrows.com" rel="nofollow noopener noreferrer" target="_blank"> lmarsicano@gtigrows.com </a> </td>
</tr><tr><td> 310-622-8257 </td>
<td> </td>
<td> </td>
<td> 773-354-2004 </td>
</tr></tbody></table></div>
<p> Source: Green Thumb Industries </p>
<p> <img class="lazy" data-src="https://www.globenewswire.com/newsroom/ti?nf=ODE1OTYyOCMzOTk1MzE0IzIxMjQ5MTA=" data-srcset="" height="1" src="https://www.globenewswire.com/newsroom/ti?nf=ODE1OTYyOCMzOTk1MzE0IzIxMjQ5MTA=" srcset="" width="1"/><br/><img class="lazy" data-src="https://ml.globenewswire.com/release/track/95a92035-2e06-496f-a92d-dea0f97dff7b" data-srcset="" height="1" referrerpolicy="no-referrer-when-downgrade" src="https://ml.globenewswire.com/release/track/95a92035-2e06-496f-a92d-dea0f97dff7b" srcset="" width="1"/></p>
<p> <a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/8ee641c4-5c01-414f-9b9c-93b8e9b761b0" rel="noopener noreferrer" target="_blank"> <img alt="Primary Logo" border="0" class="lazy" data-src="https://ml.globenewswire.com/media/8ee641c4-5c01-414f-9b9c-93b8e9b761b0/small/gti-new-logo-high-res-jpg.jpg" data-srcset="" height="41" src="https://ml.globenewswire.com/media/8ee641c4-5c01-414f-9b9c-93b8e9b761b0/small/gti-new-logo-high-res-jpg.jpg" srcset="" width="150"/></a> </p>
</div>
<p>News Provided by GlobeNewswire via QuoteMedia</p>
<p></p><div class="cp-text-ad"><div class="row text-ad-ofie">
<div class="ad-image large-4 medium-4 small-12 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<img alt="Cannabis Free Report Cover" class="hide-for-small-only" src="https://cdn.investingnews.com/app/uploads/2020/05/Profiting-from-Cannabis-Industry-3D.jpg" title="Profiting from the Cannabis Industry"/></a></div>
<div class="ad-copy large-8 medium-8 small-11 columns"><a href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing">
<h2 align="center" class="ofie">Find out what experts say about profiting from the cannabis market in 2021!</h2></a>
<h5 align="center" class="subheadline">Read our FREE 2021 cannabis outlook report!</h5>
<div align="center"><a class="button red radius" href="https://investingnews.com/free-report-online/investing-in-medical-cannabis-and-legal-cannabis-stocks/" id="Type: Outlook, Category: Cannabis Investing"> Give me my free report! </a></div>
</div>
<!-- end large-8 -->
</div></div>
Keep reading...
Show less
Southern California Grocery Chain Jensen’s Begins Carrying KOIOS Nootropic Beverages
February 25 | 2021
All five flavours of the Company’s KOIOS™ nootropic beverage product are now being carried by Jensen’s, a regional supermarket chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. This placement of KOIOS™ follows several other recent placements of the Company’s beverage products in regional supermarket chains across the United States as part of a strategy to passively build market share in specific geographical areas.
Koios Beverage Corp. (CSE: KBEV; OTC: KBEVF) (the “Company” or “Koios”) is pleased to announce that the full range of five flavours of its KOIOS ™ nootropic beverages can now be purchased at all grocery stores operated by Jensen’s Foods (“Jensen’s”), a long-established family-owned grocery chain operating in the San Diego, Los Angeles, and Palm Springs areas of Southern California. In a press release dated February 19, 2021 the Company announced another chain-wide placement of KOIOS ™ nootropic beverages on the west coast of the United States with Market of Choice in Oregon. With this placement of KOIOS ™ in Jensen’s supermarkets, the Company’s beverage products are now carried in approximately 180 retail stores on the west coast, out of a total of more than 4,000 retail stores nationwide.
<p> The first Jensen’s market was established in California in 1940 in Blue Jay (San Bernardino county), later expanding into a 25,000 square foot building which allowed for the addition of a bakery using traditional Danish recipes. The growth of Jensen’s into a regional chain was led by its current President Gene Fulton, who began working at Jensen’s as a cleaner at age 17 in 1957, and in 1970 arranged to purchase the market from its current owner Einer Jensen upon his retirement. In 1981, this acquisition was completed and Mr. Fulton promptly opened a new store in Cedar Glen, CA named <em> Jensen’s Minute Shoppe </em> ; a convenience store concept which is still in operation today along with another location in Rancho Mirage, CA. Throughout the remainder of the 20th century, 2000s and 2010s, Jensen’s continued to open new supermarkets across Southern California, including locations in mountain communities such as Wrightwood and Running Springs. Jensen’s now operates a total of eight grocery stores, which have proven to be remarkably desirable workplaces with several employees having worked for the Jensen’s chain for nearly 40 years. </p>
<p> More information about Jensen’s can be found on its website: <a href="http://jensensfoods.com/" rel="nofollow noopener noreferrer" target="_blank"> <u> http://jensensfoods.com/ </u> </a> </p>
<p> A photo accompanying this announcement is available at <a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/d9c55e45-c3e6-4884-a9ec-2e6b532766f0" rel="nofollow noopener noreferrer" target="_blank"> https://www.globenewswire.com/NewsRoom/AttachmentNg/d9c55e45-c3e6-4884-a9ec-2e6b532766f0 </a> </p>
<p align="left"> <strong> <em> Image Source: </em> </strong> <a href="https://www.facebook.com/jensensfoods/photos/a.133930629994829/2783720275015838" rel="nofollow noopener noreferrer" target="_blank"> <em> <u> Jensen’s Foods (Facebook) </u> </em> </a> </p>
<p align="left"> <strong> Readers using news aggregation services may be unable to view the media above. Please access the Company’s profile on SEDAR for a version of this press release containing all published media. </strong> </p>
<p> To date in 2021, the Company has added its <em> KOIOS™ </em> nootropic beverage and <em> Fit Soda </em> ™ functional beverage products to numerous regional grocery chains across the United States as part of a strategy to passively build market share and gather sales performance data of its products in specific geographical areas. Based on outcomes from these placements, the Company and its distribution partners can shape near-term and long-term decisions for a given region using such results as a baseline. Additionally, the Company anticipates that it could leverage these regional market placements to potentially secure shelf space in larger grocery chains in the United States. </p>
<p> Koios Chief Executive Officer Chris Miller commented, “California is a unique market when it comes to beverages because there have been numerous efforts by lawmakers to impose a statewide ‘Soda Tax’ or ‘Sugary Drink Tax’, and such taxes have been put into effect by several California municipalities to include San Francisco, Oakland, and Berkeley. At Koios, we pride ourselves in producing sugar-free beverages that have been shown to provide unique benefits which are relevant to a wide range of consumers. In the 80 years that Jensen’s has been in business under family ownership, it goes without saying that they know a thing or two about picking products that are relevant to their client base in Southern California, and it is an honour for <em> KOIOS™ </em> to be among the latest additions to their product mix.” </p>
<p> On behalf of the Board of Directors of the Company, </p>
<p> <strong> KOIOS BEVERAGE CORP. </strong> </p>
<p> “Chris Miller” </p>
<p> Chris Miller, CEO, and Director </p>
<p> For further information, please contact: </p>
<p> Gina Burrus <br/> 844-255-6467 <br/><a href="mailto:gina@koiosbeveragecorp.com" rel="nofollow noopener noreferrer" target="_blank"> <u> gina@koiosbeveragecorp.com </u> </a> </p>
<p> THE CANADIAN SECURITIES EXCHANGE (CSE) HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE. </p>
<p> <strong> About Koios Beverage Corp. </strong> </p>
<p> The Company is an emerging functional beverage company which has an available distribution network of more than 4,400 retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, Muscle Foods USA, KeHE, and Wishing-U-Well. Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants. Koios products have been shown to enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity. Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain. </p>
<p> Koios produces one of the only drinks in the world infused with MCT oil. MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: <a href="https://www.koiosbeveragecorp.com" rel="nofollow noopener noreferrer" target="_blank"> <u> https://www.koiosbeveragecorp.com </u> </a> . </p>
<p> <strong> Forward-Looking Statements </strong> </p>
<p> This news release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. Often, but not always, forward-looking information and information can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Forward-looking information in this news release includes statements regarding: Potential outcomes from <em> KOIOS </em> ™ being carried by Jensen’s grocery stores in Southern California. The forward-looking information reflects management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking information. Although the Company believes that the assumptions and factors used in preparing the forward-looking information are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. Factors that could cause actual results or events to differ materially from current expectations include: (i) adverse market conditions; (ii) changes to the growth and size of the functional beverage markets; and (iii) other factors beyond the control of the Company. The Company operates in a rapidly evolving environment. New risk factors emerge from time to time, and it is impossible for the Company’s management to predict all risk factors, nor can the Company assess the impact of all factors on Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking information. The forward-looking information included in this news release are made as of the date of this news release and the Company expressly disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events or otherwise, except as required by applicable law. </p>
<p> The statements in this news release have not been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking the Company’s products will vary from person to person. No claims or guarantees can be made as to the effects of the Company’s products on an individual’s health and well-being. The Company’s products are not intended to diagnose, treat, cure, or prevent any disease. </p>
<p> This news release may contain trademarked names of third-party entities (or their respective offerings with trademarked names) typically in reference to (i) relationships had by Koios with such third-party entities as referred to in this release and/or (ii) client/vendor/service provider parties whose relationship with Koios is/are referred to in this release. All rights to such trademarks are reserved by their respective owners or licensees. </p>
<p></p>
<p> <img class="lazy" data-src="https://www.globenewswire.com/newsroom/ti?nf=ODE1OTY5MSMzOTk1NDg5IzIwOTAwMjM=" data-srcset="" height="1" src="https://www.globenewswire.com/newsroom/ti?nf=ODE1OTY5MSMzOTk1NDg5IzIwOTAwMjM=" srcset="" width="1"/><br/><img class="lazy" data-src="https://ml.globenewswire.com/release/track/c439a640-2359-48ee-908e-f5496a2cda98" data-srcset="" height="1" referrerpolicy="no-referrer-when-downgrade" src="https://ml.globenewswire.com/release/track/c439a640-2359-48ee-908e-f5496a2cda98" srcset="" width="1"/></p>
<p> <a href="https://www.globenewswire.com/NewsRoom/AttachmentNg/69225798-53e0-46a5-b563-b49071c3918c" rel="noopener noreferrer" target="_blank"> <img alt="Primary Logo" border="0" class="lazy" data-src="https://ml.globenewswire.com/media/69225798-53e0-46a5-b563-b49071c3918c/small/koios-logo-1-jpg.jpg" data-srcset="" height="150" src="https://ml.globenewswire.com/media/69225798-53e0-46a5-b563-b49071c3918c/small/koios-logo-1-jpg.jpg" srcset="" width="150"/></a> </p>
</div>
<p>News Provided by GlobeNewswire via QuoteMedia</p>
<p></p>
Keep reading...
Show less
Lobe Sciences to Present at Psychedelic Capital Virtual Investor Conference
February 24 | 2021
Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) announces that Philip Young, CEO and Director, and Maghsoud Dariani, Chief Science Officer will be presenting on Thursday, February 25th, 2021 at 5:45 pm EST at “The Gold Standard in Psychedelic Investment, Psychedelic Capital Virtual Investment Conference”, a platform showcasing the top companies, latest IPOs, newest opportunities, and deepest industry insights.
As a presenting sponsor, the Company will connect directly with some of the earliest moving investors in the psychedelic industry and reach an audience of 2,000+ investors. Presentations are 30 minutes in length, with 10 minutes allocated to a one-on-one Q&A session with the audience.
<p>Investors can register to the event using the following link:<a href="https://www.newsfilecorp.com/redirect/pxWpcwaJ1" rel="noopener noreferrer" target="_blank"><br/>https://microdose.buzz/shop/psychedelic-capital/psychedelic-capital-feb-2021/</a></p>
<p>Recent Company highlights & topics to be discussed include:</p>
<p>– Executed definitive agreement for the $32,000,000 sale of Cowlitz Cannabis Assets;<br/>– The successful completion and testing of the proof-of-concept prototype of Lobe’s proprietary nasal mist device;<br/>– Pre-clinical study of psilocybin plus NAC for treatment of PTSD and mTBI with the University of Miami;<br/>– The appointment of Philip Young as CEO and Director;<br/>– The closing of an upsized $3,445,847 non-brokered private placement;<br/>– The appointment of Jonathan Gilbert as Executive Chairman.</p>
<p><b>About <a href="https://investingnews.com/company-profiles/lobe-sciences-cse-lobe/">Lobe Sciences Ltd.</a></b></p>
<p><a href="https://investingnews.com/company-profiles/lobe-sciences-cse-lobe/">Lobe Sciences</a> is a life sciences company focused on psychedelic medicines. The Company, through collaborations with industry leading partners, is engaged in drug research and development using psychedelic compounds and the development of innovative devices and delivery mechanisms to improve mental health and wellness.</p>
<p><b>For further information please contact: </b></p>
<p><b><a href="https://investingnews.com/company-profiles/lobe-sciences-cse-lobe/">Lobe Sciences Ltd.</a></b><br/>Philip J Young, CEO<br/><a href="mailto:info@lobesciences.com" rel="noopener noreferrer" target="_blank">info@lobesciences.com</a><br/>Tel: (949) 505-5623</p>
<p><i>THE CSE HAS NOT REVIEWED AND DOES NOT ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS RELEASE.</i></p>
<p><i><b>Disclaimer for Forward Looking Statements </b></i></p>
<p><i>This news release contains forward-looking statements relating to the future operations of the Company and other statements that are not historical facts. Forward-looking statements are often identified by terms such as “will”, “may”, “should”, “anticipate”, “expects” and similar expressions. All statements other than statements of historical fact included in this release, including statements regarding the future plans and objectives of the Company, progression with nasal mist device engineering and commercialization, the pursuit of M&A initiatives, development of effective delivery methods and commercialization potential of the nasal mist device, research and development using NAC and psilocybin and growth of the business, are forward looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate, and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations are risks detailed from time to time in the filings made by the Company with securities regulations. Readers are cautioned that assumptions used in the preparation of the forward-looking statements may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company, including changes to the regulatory environment; and that the current Board and management may not be able to attain the Company’s corporate goals and objectives. As a result, the Company cannot guarantee that any forward-looking statement will materialize and the reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made only as of the date of this news release and the Company does not intend to update any of the included forward-looking statements except as expressly required by applicable Canadian securities laws.</i></p>
<p id="corporateNewsLogoContainer"><img alt="Corporate Logo" class="lazy" data-src="https://orders.newsfilecorp.com/files/6461/75375_c954e00204dba9d2_logo.jpg" data-srcset="" id="corporateNewsLogo" src="https://orders.newsfilecorp.com/files/6461/75375_c954e00204dba9d2_logo.jpg" srcset=""/></p>
<p id="corporateLinkBack">To view the source version of this press release, please visit <a href="https://www.newsfilecorp.com/redirect/YvrEhpWmm" rel="noopener noreferrer" target="_blank">https://www.newsfilecorp.com/release/75375</a></p>
<p><img alt="" class="lazy" data-src="https://www.newsfilecorp.com/newsinfo/75375/310" data-srcset="" src="https://www.newsfilecorp.com/newsinfo/75375/310" srcset=""/></p>
</div>
<p>News Provided by Newsfile via QuoteMedia</p>
<p></p><div class="stock-information sidebar-block">
<div class="title">Request an Investor Kit: <h3>Lobe Sciences</h3></div>
<form action="https://investingnews.com" id="subscribe_per_category" method="POST">
<div class="form-column left">
<input name="profiles_only" type="hidden" value="yes"/><input name="subscription_form" type="hidden" value="yes"/><input name="subscribe_company_profile_form" type="hidden" value="1"/><input name="source" type="hidden" value="https://investingnews.com/news/cannabis-investing/lobe-sciences-to-present-at-psychedelic-capital-virtual-investor-conference/"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="form_name" type="hidden" value="subscribe_cprofile_use_posts"/><input class="referrer" name="referral_url" type="hidden" value=""/><input name="cprofiles[]" type="hidden" value="Tzo4OiJzdGRDbGFzcyI6NDp7czoyOiJpZCI7czozNjoiODY3MWZiY2MtYjE5MS01ZmQ2LWM0ODktNWZiMmE5NTNmZjcxIjtzOjQ6Im5hbWUiO3M6MTM6IkxvYmUgU2NpZW5jZXMiO3M6NDoid3BpZCI7czo5OiIxMDE1OTE5NjUiO3M6MzoidXJsIjtzOjA6IiI7fQ=="/><input class="form-control" id="FirstName" name="first_name" placeholder="First Name" required="" type="text" value=""/><input class="form-control" id="LastName" name="last_name" placeholder="Last Name" required="" type="text" value=""/><input class="form-control" id="email" name="email" placeholder="Email" required="" type="email" value=""/><input class="form-control" id="phone" name="user_phone" pattern="[\+\s0-9]{3,15}" placeholder="Phone" title="Telephone number. Only digits and space signs are allowed" type="tel" value=""/></div>
<div class="form-column right">
<div class="extra-input">
<input id="AccreditedInvestor" name="accredited_investor" type="checkbox"/><label class="checkbox-label" for="AccreditedInvestor">
Include me in the <b>Accredited Investor</b> email list
<span class="help">
<i aria-hidden="true" class="fa fa-question-circle"></i>
<div class="help-box bigger">
Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above.
</div>
</span>
</label>
</div>
<div class="more">
<input class="btn btn-primary" type="submit" value="Get More information"/></div>
<p class="legend">By completing this form, you are giving consent to receive communication from Lobe Sciences using the contact information you provide. And remember you can unsubscribe at any time.</p>
</div>
</form>
</div>
Keep reading...
Show less